Menu
Back to Archived Journals » International Journal of Interferon, Cytokine and Mediator Research » Volume 4
The role of inflammation in diabetic cardiomyopathy
Authors Nunes S, Soares , Pereira F, Reis F
Received 4 May 2012
Accepted for publication 12 June 2012
Published 24 July 2012 Volume 2012:4 Pages 59—73
DOI https://doi.org/10.2147/IJICMR.S21679
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Sara Nunes, Edna Soares, Frederico Pereira, Flávio Reis
Laboratory of Pharmacology and Experimental Therapeutics, IBILI, Faculty of Medicine, Coimbra University, Coimbra, Portugal
Abstract: Type 2 diabetes mellitus (T2DM) is a major risk factor for developing cardiovascular disease and represents a serious public health problem, with high rates of mortality and morbidity worldwide. T2DM etiology is complex and multifactorial and is associated with several complications, including those at myocardium level. Diabetic cardiomyopathy (DCM) is viewed as a specific cardiomyopathy and defined as structural and functional changes in the myocardium due to metabolic and cellular abnormalities induced by diabetes. T2DM has long been classified as an inflammatory disease and recent studies have identified the importance of the inflammatory process in the development and progression of heart failure. In this review, the authors outline the main mechanisms underlying the potential contribution of the inflammatory process in the development and evolution of DCM. In addition, potential therapeutic strategies against inflammation of DCM are discussed.
Keywords: type 2 diabetes mellitus, inflammation, myocardium, inflammatory process
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.